Skye Bioscience, Inc.
SKYE
Last
$1.69
Day
+0.6%
1y
-87.8%
5y
-99.1%
52w
-88.1%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0930d
EMA 21
1.80
EMA 50
2.51
EMA 200
6.59
20d high
-22.2%
5y high
-99.2%
5y range
0th
Positions held
Your positionsSKYE isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-15
Hold
avoid
Signal
Strong Sell
Target
$1.94
Stop
$1.47
Stop distance
13.0%
Target vs last
+14.8%
Fundamentals
| Market cap | $7.44M | Enterprise value | -$2.45M | Trailing P/E | — | Forward P/E | -0.23 |
| PEG | — | Price / book | -14.87 | Beta | 2.86 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -2.3% | ROA | -95.1% | Debt / equity | — |
| Current ratio | 0.95 | Free cash flow | -$18.71M | Analyst recommendation | none | Mean target | $68.00 |
| 52w high | $14.08 | 52w low | $1.50 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$10.8M | -$12.5M | -$14.4M | -$12.8M | -$17.6M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$7.8M | -$12.7M | -$14.9M | -$13.3M | -$18.2M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$55.9M | -$26.6M | -$37.6M | -$19.5M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$58.2M | -$36.4M | -$13.7M | -$12.1M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-08-17 · Skye Bioscience Inc (SKYE) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Fibrex ...
2026-08-14 · Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings
2026-07-17 · The weight-loss drugs boom is creating both winners and wipeouts: One Big Investment Idea
Price (daily)
Full chart · RSI · MACD · patternsSKYE · daily-1.8% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin